DOJ Accuses Yale School of Medicine of Admissions Discrimination
The U.S. Department of Justice (DOJ) has formally alleged that the Yale School of Medicine discriminates against White and Asian American applicants. This accusation comes after a thorough yearlong investigation aimed at determining the university’s adherence to a 2023 Supreme Court decision, which banned race-conscious admissions practices.
According to the DOJ, documents and communications gathered during the investigation indicate that Yale has intentionally factored race into its admissions decisions, thereby circumventing the Supreme Court’s ruling.
Further findings from the DOJ claim that the medical school’s admissions committee favored Black and Hispanic candidates over those from other racial backgrounds, even when those individuals had comparable or better academic achievements. Investigators noted that Yale’s internal data seemed to prioritize meeting specific racial goals rather than conducting an unbiased, holistic review.
Yale has denied these allegations, maintaining that its admissions practices are legally justified. However, the DOJ contends that relying on racial preferences contradicts Title VI of the Civil Rights Act of 1964, which prohibits discrimination based on race, color, or national origin in federally funded programs.
“Yale has continued its race-based admissions program despite the Supreme Court and the public’s clear mandate for reform. This Department will continue to shed light on these illegal practices and demand that institutions of higher education comply with federal law,” said Assistant Attorney General Harmeet K. Dhillon from the DOJ’s Civil Rights Division.
In reviewing median GPA and standardized test scores by race, the investigation discovered that Black candidates had “as much as 29 times higher odds of getting an interview for admission than an equally strong Asian applicant with similar academic qualifications.”
“This consistent difference in test scores between students of different racial groups is substantial and cannot be attributed to coincidence,” the DOJ noted.
These recent allegations against the Yale School of Medicine come on the heels of similar claims against the David Geffen School of Medicine at UCLA, where the DOJ had made accusations of discriminatory admissions practices earlier this month.
This initiative is part of a broader campaign by the Trump administration aimed at dismantling racially biased policies in prestigious medical schools. Federal officials argue that these institutions have prioritized diversity and social equity “goals” over merit-based criteria, thus violating existing civil rights laws.
As part of this systematic effort to address perceived unfair social engineering in healthcare education, the DOJ has broadened its inquiries beyond Yale and UCLA, launching investigations into the admissions practices at Stanford University, UC San Diego, and Ohio State University.
The purpose of these investigations is to determine whether these medical schools are employing hidden racial preferences or “proxy” variables to circumvent the Supreme Court’s prohibition of affirmative action.
